Logo image of GYL.OL

GYLDENDAL ASA (GYL.OL) Stock Fundamental Analysis

OSL:GYL - Euronext Oslo - NO0004288200 - Common Stock - Currency: NOK

424  0 (0%)

Fundamental Rating

4

GYL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 56 industry peers in the Specialty Retail industry. GYL has an average financial health and profitability rating. GYL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year GYL was profitable.
In the past year GYL had a positive cash flow from operations.
Of the past 5 years GYL 4 years were profitable.
GYL had a positive operating cash flow in each of the past 5 years.
GYL.OL Yearly Net Income VS EBIT VS OCF VS FCFGYL.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

GYL has a Return On Assets (1.12%) which is in line with its industry peers.
GYL has a Return On Equity of 2.76%. This is comparable to the rest of the industry: GYL outperforms 57.14% of its industry peers.
With a Return On Invested Capital value of 3.68%, GYL perfoms like the industry average, outperforming 53.57% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for GYL is below the industry average of 8.99%.
Industry RankSector Rank
ROA 1.12%
ROE 2.76%
ROIC 3.68%
ROA(3y)0.07%
ROA(5y)1.15%
ROE(3y)0.2%
ROE(5y)2.81%
ROIC(3y)5.19%
ROIC(5y)5.58%
GYL.OL Yearly ROA, ROE, ROICGYL.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5

1.3 Margins

GYL has a Profit Margin of 0.93%. This is comparable to the rest of the industry: GYL outperforms 58.93% of its industry peers.
In the last couple of years the Profit Margin of GYL has declined.
Looking at the Operating Margin, with a value of 2.17%, GYL is in line with its industry, outperforming 55.36% of the companies in the same industry.
GYL's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 58.82%, GYL belongs to the best of the industry, outperforming 89.29% of the companies in the same industry.
GYL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.17%
PM (TTM) 0.93%
GM 58.82%
OM growth 3Y6.43%
OM growth 5Y3.77%
PM growth 3Y-18.1%
PM growth 5Y-12.68%
GM growth 3Y1.29%
GM growth 5Y1.61%
GYL.OL Yearly Profit, Operating, Gross MarginsGYL.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GYL is destroying value.
The number of shares outstanding for GYL remains at a similar level compared to 1 year ago.
Compared to 5 years ago, GYL has about the same amount of shares outstanding.
GYL has a worse debt/assets ratio than last year.
GYL.OL Yearly Shares OutstandingGYL.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
GYL.OL Yearly Total Debt VS Total AssetsGYL.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.33 indicates that GYL is not a great score, but indicates only limited risk for bankruptcy at the moment.
GYL has a Altman-Z score (2.33) which is in line with its industry peers.
GYL has a debt to FCF ratio of 2.10. This is a good value and a sign of high solvency as GYL would need 2.10 years to pay back of all of its debts.
The Debt to FCF ratio of GYL (2.10) is better than 85.71% of its industry peers.
GYL has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.44, GYL is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 2.1
Altman-Z 2.33
ROIC/WACC0.53
WACC6.89%
GYL.OL Yearly LT Debt VS Equity VS FCFGYL.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.12 indicates that GYL should not have too much problems paying its short term obligations.
With a Current ratio value of 1.12, GYL perfoms like the industry average, outperforming 44.64% of the companies in the same industry.
GYL has a Quick Ratio of 1.12. This is a bad value and indicates that GYL is not financially healthy enough and could expect problems in meeting its short term obligations.
GYL's Quick ratio of 0.54 is in line compared to the rest of the industry. GYL outperforms 53.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.54
GYL.OL Yearly Current Assets VS Current LiabilitesGYL.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

GYL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 146.35%, which is quite impressive.
Measured over the past years, GYL shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.29% on average per year.
Looking at the last year, GYL shows a small growth in Revenue. The Revenue has grown by 1.67% in the last year.
The Revenue has been growing slightly by 6.17% on average over the past years.
EPS 1Y (TTM)146.35%
EPS 3Y-15.89%
EPS 5Y-7.29%
EPS Q2Q%83.65%
Revenue 1Y (TTM)1.67%
Revenue growth 3Y2.71%
Revenue growth 5Y6.17%
Sales Q2Q%2.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GYL.OL Yearly Revenue VS EstimatesGYL.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

4. Valuation

4.1 Price/Earnings Ratio

GYL is valuated quite expensively with a Price/Earnings ratio of 51.21.
GYL's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of GYL to the average of the S&P500 Index (26.34), we can say GYL is valued expensively.
Industry RankSector Rank
PE 51.21
Fwd PE N/A
GYL.OL Price Earnings VS Forward Price EarningsGYL.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

GYL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GYL is cheaper than 87.50% of the companies in the same industry.
GYL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GYL is cheaper than 80.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.67
EV/EBITDA 3.56
GYL.OL Per share dataGYL.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800 1K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.83%, GYL is not a good candidate for dividend investing.
GYL's Dividend Yield is a higher than the industry average which is at 4.89.
Compared to an average S&P500 Dividend Yield of 2.40, GYL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.83%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
GYL.OL Yearly Income VS Free CF VS DividendGYL.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

GYLDENDAL ASA

OSL:GYL (6/17/2025, 7:00:00 PM)

424

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.89%
Ins Owner ChangeN/A
Market Cap996.40M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.83%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 51.21
Fwd PE N/A
P/S 0.36
P/FCF 3.67
P/OCF 2.86
P/B 1.08
P/tB 1.54
EV/EBITDA 3.56
EPS(TTM)8.28
EY1.95%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)115.58
FCFY27.26%
OCF(TTM)148.22
OCFY34.96%
SpS1162.26
BVpS392.66
TBVpS274.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 2.76%
ROCE 4.14%
ROIC 3.68%
ROICexc 4.63%
ROICexgc 6.13%
OM 2.17%
PM (TTM) 0.93%
GM 58.82%
FCFM 9.94%
ROA(3y)0.07%
ROA(5y)1.15%
ROE(3y)0.2%
ROE(5y)2.81%
ROIC(3y)5.19%
ROIC(5y)5.58%
ROICexc(3y)6.6%
ROICexc(5y)7.99%
ROICexgc(3y)8.71%
ROICexgc(5y)10.98%
ROCE(3y)5.84%
ROCE(5y)6.29%
ROICexcg growth 3Y0.65%
ROICexcg growth 5Y2.34%
ROICexc growth 3Y2.82%
ROICexc growth 5Y4.07%
OM growth 3Y6.43%
OM growth 5Y3.77%
PM growth 3Y-18.1%
PM growth 5Y-12.68%
GM growth 3Y1.29%
GM growth 5Y1.61%
F-Score6
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 2.1
Debt/EBITDA 1.21
Cap/Depr 27.77%
Cap/Sales 2.81%
Interest Coverage 2.64
Cash Conversion 103.84%
Profit Quality 1065.21%
Current Ratio 1.12
Quick Ratio 0.54
Altman-Z 2.33
F-Score6
WACC6.89%
ROIC/WACC0.53
Cap/Depr(3y)32.9%
Cap/Depr(5y)39.21%
Cap/Sales(3y)3.38%
Cap/Sales(5y)3.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)146.35%
EPS 3Y-15.89%
EPS 5Y-7.29%
EPS Q2Q%83.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.67%
Revenue growth 3Y2.71%
Revenue growth 5Y6.17%
Sales Q2Q%2.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y527.57%
EBIT growth 3Y9.31%
EBIT growth 5Y10.17%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y140.48%
FCF growth 3Y16.08%
FCF growth 5Y1.96%
OCF growth 1Y66.27%
OCF growth 3Y3.98%
OCF growth 5Y2.82%